Skip to content
Home/Companies/Pharma/ALIZÉ Pharma II SAS

ALIZÉ Pharma II SAS

Pharma·France·Exited 2016·Held 2yr
Entry
2014
Hold
2yr
Exit
2016

Who owns ALIZÉ Pharma II SAS?

ALIZÉ Pharma II SAS is a French Pharma company, now owned by Jazz Pharmaceuticals, which acquired it in 2016 from Turenne Groupe.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Turenne Groupe
Investor
Turenne Groupe
Capital Santé 2 · 2020 · Growth

Key facts

HQFrance
SectorPharma
Exit Type
Trade Sale
Buyer
Jazz Pharmaceuticals
Exit Year
2016

More from Capital Santé 2

Other portfolio companies in the same fund.

Le Petit Souk
Active
ConsumerFrance· 2026
M&C3i
Active
SoftwareFrance· 2026
Agrotech
Active
ConstructionFrance· 2025
Anothercorp.
Active
ConsumerFrance· 2025
Groupe Colibri – Promesse de Fleurs
Active
ConsumerFrance· 2025
Kimialys
Active
IndustrialsFrance· 2025

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns ALIZÉ Pharma II SAS?

ALIZÉ Pharma II SAS is now owned by Jazz Pharmaceuticals, which acquired it in 2016 from Turenne Groupe.

When did Jazz Pharmaceuticals acquire ALIZÉ Pharma II SAS?

Jazz Pharmaceuticals acquired ALIZÉ Pharma II SAS in 2016, buying from Turenne Groupe.

Who did ALIZÉ Pharma II SAS sell to?

Turenne Groupe sold ALIZÉ Pharma II SAS to Jazz Pharmaceuticals in 2016 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue